Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 581

1.

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A.

Lancet Respir Med. 2020 Apr 3. pii: S2213-2600(20)30167-3. doi: 10.1016/S2213-2600(20)30167-3. [Epub ahead of print] No abstract available.

PMID:
32251625
2.

PRDM15 Is Associated with Risk of Chronic Obstructive Pulmonary Disease in a Rural Population in Chile.

Hosgood Iii HD, Díaz-Peña R, Blansky D, Jaime S, Parra V, Boekstegers F, Bermejo JL, García-Valero J, Montes JF, Valdivia G, Miravitlles M, Agustí À, Silva RS, Olloquequi J.

Respiration. 2020 Mar 27:1-9. doi: 10.1159/000506649. [Epub ahead of print]

PMID:
32222710
3.

Blood eosinophil count in the general population: typical values and potential confounders.

Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R.

Eur Respir J. 2020 Feb 14. pii: 1901874. doi: 10.1183/13993003.01874-2019. [Epub ahead of print]

PMID:
32060069
4.

Outcomes and cost of lung cancer patients treated surgically or medically in Catalunya: cost-benefit implications for lung cancer screening programs.

Guzman R, Guirao À, Vela E, Clèries M, García-Altés A, Sagarra J, Magem D, Espinas JA, Grau J, Nadal C, Agusti À, Molins L.

Eur J Cancer Prev. 2020 Feb 7. doi: 10.1097/CEJ.0000000000000566. [Epub ahead of print]

PMID:
32039928
5.

The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.

Vílchez-Oya F, Sánchez-Schmidt JM, Agustí A, Pros A.

Clin Rheumatol. 2020 Jan 23. doi: 10.1007/s10067-020-04952-5. [Epub ahead of print] Review.

PMID:
31974818
6.

BRONCHIAL INFECTION AND temporal evolution OF bronchiectasis in patients with chronic obstructive pulmonary disease.

Martinez-Garcia MA, de la Rosa-Carrillo D, Soler-Cataluña JJ, Catalan-Serra P, Ballester M, Roca Vanaclocha Y, Agramunt M, Ballestin J, Garcia-Ortega A, Oscullo G, Navarro-Soriano C, Agusti A.

Clin Infect Dis. 2020 Jan 22. pii: ciaa069. doi: 10.1093/cid/ciaa069. [Epub ahead of print]

PMID:
31967312
7.

The Use of Hydrodissection in Nipple- and Skin-sparing Mastectomy: A Retrospective Cohort Study.

Tasoulis MK, Agusti A, Karakatsanis A, Montgomery C, Marshall C, Gui G.

Plast Reconstr Surg Glob Open. 2019 Nov 14;7(11):e2495. doi: 10.1097/GOX.0000000000002495. eCollection 2019 Nov.

8.

Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity.

Perea L, Rodrigo-Troyano A, Cantó E, Domínguez-Álvarez M, Giner J, Sanchez-Reus F, Villar-García J, Quero S, García-Núñez M, Marín A, Monsó E, Faner R, Agustí A, Vidal S, Sibila O.

Respir Res. 2020 Jan 13;21(1):21. doi: 10.1186/s12931-020-1278-5.

9.

Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection and Pneumonia Risk in Chronic Obstructive Pulmonary Disease: A Network Analysis.

Martinez-Garcia MA, Faner R, Oscullo G, la Rosa-Carrillo D, Soler-Cataluña JJ, Ballester M, Agusti A.

Am J Respir Crit Care Med. 2020 Jan 10. doi: 10.1164/rccm.201908-1550OC. [Epub ahead of print]

PMID:
31922913
10.

Chronic obstructive pulmonary disease at the beginning of the XXI Century.

Agusti A, Zhang J.

J Thorac Dis. 2019 Nov;11(11):E210-E213. doi: 10.21037/jtd.2019.10.50. No abstract available.

11.

Update on the Pathogenesis of COPD. Reply.

Agustí A, Hogg JC.

N Engl J Med. 2019 Dec 19;381(25):2484. doi: 10.1056/NEJMc1914437. No abstract available.

PMID:
31851816
12.

Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.

Iglesias-Lopez C, Obach M, Vallano A, Agustí A, Montané J.

Crit Rev Toxicol. 2019 Aug;49(7):580-596. doi: 10.1080/10408444.2019.1689380. Epub 2019 Dec 17.

PMID:
31846383
13.

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries.

Stawowczyk E, Malinowski KP, Kawalec P, Bobiński R, Siwiec J, Panteli D, Eckhardt H, Simoens S, Agusti A, Dooms M, Pilc A.

Front Pharmacol. 2019 Nov 27;10:1279. doi: 10.3389/fphar.2019.01279. eCollection 2019.

14.

An imported case of e-cigarette or vaping associated lung injury in Barcelona.

Casanova GS, Amaro R, Soler N, Sánchez M, Badía JR, Barberà JA, Agustí A.

Eur Respir J. 2020 Feb 6;55(2). pii: 1902076. doi: 10.1183/13993003.02076-2019. Print 2020 Feb. No abstract available.

PMID:
31806720
15.

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease.

Agusti A, Faner R.

Am J Respir Crit Care Med. 2020 Feb 1;201(3):263-265. doi: 10.1164/rccm.201911-2123ED. No abstract available.

16.

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-1141. doi: 10.5588/ijtld.19.0397.

PMID:
31718748
17.

COPD: Challenges and opportunities.

Agustí A.

Respirology. 2020 Feb;25(2):132-133. doi: 10.1111/resp.13723. Epub 2019 Oct 30. No abstract available.

18.

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART.

Samperiz G, Fanjul F, Valera JL, Lopez M, Rios Á, Peñaranda M, Campins A, Riera M, Agusti A.

PLoS One. 2019 Oct 29;14(10):e0224510. doi: 10.1371/journal.pone.0224510. eCollection 2019.

19.

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.

Criner GJ, Celli BR, Singh D, Agusti A, Papi A, Jison M, Makulova N, Shih VH, Brooks L, Barker P, Martin UJ, Newbold P.

Lancet Respir Med. 2020 Feb;8(2):158-170. doi: 10.1016/S2213-2600(19)30338-8. Epub 2019 Sep 28.

PMID:
31575508
20.

Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Agustí A, Hogg JC.

N Engl J Med. 2019 Sep 26;381(13):1248-1256. doi: 10.1056/NEJMra1900475. Review. No abstract available.

PMID:
31553836
21.

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.

Iglesias-López C, Agustí A, Obach M, Vallano A.

Front Pharmacol. 2019 Aug 30;10:921. doi: 10.3389/fphar.2019.00921. eCollection 2019.

22.

Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?

Cuerpo S, Moisés J, Hernández-González F, Benegas M, Ramirez J, Sánchez M, Agustí À, Sellares J.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119869334. doi: 10.1177/1479973119869334.

23.

Clinical Fingerprinting: A Way to Address the Complexity and Heterogeneity of Bronchiectasis in Practice.

Martinez-Garcia MA, Aksamit TR, Agusti A.

Am J Respir Crit Care Med. 2020 Jan 1;201(1):14-19. doi: 10.1164/rccm.201903-0604PP. No abstract available.

PMID:
31381866
24.

UPSTAGING, CENTRALITY AND SURVIVAL IN EARLY STAGE NON-SMALL CELL LUNG CANCER VIDEO-ASSISTED SURGERY.

Boada M, Guzmán R, Montesinos M, Libreros A, Guirao A, Sánchez-Lorente D, Gimferrer JM, Agustí A, Molins L.

Lung Cancer. 2019 Aug;134:254-258. doi: 10.1016/j.lungcan.2019.06.030. Epub 2019 Jul 2.

PMID:
31319990
25.

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).

Cruz T, López-Giraldo A, Noell G, Casas-Recasens S, Garcia T, Molins L, Juan M, Fernandez MA, Agustí A, Faner R.

Respir Res. 2019 Jul 12;20(1):152. doi: 10.1186/s12931-019-1105-z.

26.

Heart and lungs in a single breath.

Washko GR, Agusti A.

Respirology. 2019 Oct;24(10):937-938. doi: 10.1111/resp.13641. Epub 2019 Jul 11. No abstract available.

27.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
28.

Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas.

Guirao A, Molins L, Ramón I, Sunyer G, Viñolas N, Marrades R, Sánchez D, Fibla JJ, Boada M, Hernández J, Guzmán R, Libreros A, Gómez-Caro A, Guerrero C, Agustí A.

Lung Cancer. 2019 Sep;135:230-233. doi: 10.1016/j.lungcan.2019.06.008. Epub 2019 Jun 15.

PMID:
31235316
29.

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.

Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, Castro-Acosta AA, Alvarez-Martinez CJ, Sibila O, Peces-Barba G, Cosio BG, Agustí A, Gea J, Monsó E.

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

30.

It's more than low BMI: prevalence of cachexia and associated mortality in COPD.

McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK.

Respir Res. 2019 May 22;20(1):100. doi: 10.1186/s12931-019-1073-3.

31.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
32.

Bronchiectasis: A Complex, Heterogeneous Disease.

Martínez-García MA, Olveira C, Máiz L, Girón RMª, Prados C, de la Rosa D, Blanco M, Agustí A.

Arch Bronconeumol. 2019 Aug;55(8):427-433. doi: 10.1016/j.arbres.2019.02.024. Epub 2019 Apr 18. English, Spanish.

PMID:
31005356
33.

Global lung health: the dangers of mild lung function impairment.

Faner R, Agusti A.

Lancet Glob Health. 2019 May;7(5):e542-e543. doi: 10.1016/S2214-109X(19)30156-1. No abstract available.

34.

Precision medicine in obstructive sleep apnoea.

Martinez-Garcia MA, Campos-Rodriguez F, Barbé F, Gozal D, Agustí A.

Lancet Respir Med. 2019 May;7(5):456-464. doi: 10.1016/S2213-2600(19)30044-X. Epub 2019 Apr 12. Review. Erratum in: Lancet Respir Med. 2019 Oct;7(10):e32.

PMID:
30987857
35.

Smoking Impairs the Immunomodulatory Capacity of Lung-Resident Mesenchymal Stem Cells in Chronic Obstructive Pulmonary Disease.

Cruz T, López-Giraldo A, Noell G, Guirao A, Casas-Recasens S, Garcia T, Saco A, Sellares J, Agustí A, Faner R.

Am J Respir Cell Mol Biol. 2019 Nov;61(5):575-583. doi: 10.1165/rcmb.2018-0351OC.

PMID:
30978114
36.

Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration.

Agusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, Maitland-van der Zee AH, Vestbo J, Allinson JP, Vanfleteren LEGW, van den Berge M, Adcock IM, Lahousse L, Brusselle G, Wedzicha JA; on behalf of the CADSET Clinical Research Collaboration; Current members of the CADSET Clinical Research Collaboration.

Eur Respir J. 2019 Mar 18;53(3). pii: 1900217. doi: 10.1183/13993003.00217-2019. Print 2019 Mar. No abstract available.

PMID:
30886026
37.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
38.

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG; participants of the Treatable Traits Down Under International Workshop; Treatable Traits Down Under International Workshop participants:.

Eur Respir J. 2019 May 9;53(5). pii: 1802058. doi: 10.1183/13993003.02058-2018. Print 2019 May. Review.

PMID:
30846468
39.

Lung function trajectories in health and disease.

Agusti A, Faner R.

Lancet Respir Med. 2019 Apr;7(4):358-364. doi: 10.1016/S2213-2600(18)30529-0. Epub 2019 Feb 11. Review.

PMID:
30765254
40.

Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Washko GR, Nardelli P, Ash SY, Vegas Sanchez-Ferrero G, Rahaghi FN, Come CE, Dransfield MT, Kalhan R, Han MK, Bhatt SP, Wells JM, Aaron CP, Diaz AA, Ross JC, Cuttica MJ, Labaki WW, Querejeta Roca G, Shah AM, Young K, Kinney GL, Hokanson JE, Agustí A, San José Estépar R.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461. doi: 10.1164/rccm.201811-2063OC.

PMID:
30758975
41.

Prospective observational study in patients with obstructive lung disease: NOVELTY design.

Reddel HK, Gerhardsson de Verdier M, Agustí A, Anderson G, Beasley R, Bel EH, Janson C, Make B, Martin RJ, Pavord I, Price D, Keen C, Gardev A, Rennard S, Sveréus A, Bansal AT, Brannman L, Karlsson N, Nuevo J, Nyberg F, Young SS, Vestbo J.

ERJ Open Res. 2019 Feb 1;5(1). pii: 00036-2018. doi: 10.1183/23120541.00036-2018. eCollection 2019 Feb.

42.

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease.

Jiménez D, Agustí A, Monreal M, Otero R, Huisman MV, Lobo JL, Quezada A, Jara-Palomares L, Hernando A, Tabernero E, Marcos P, Ruiz-Artacho P, Ballaz A, Bertoletti L, Couturaud F, Yusen R; SLICE investigators.

Clin Cardiol. 2019 Mar;42(3):346-351. doi: 10.1002/clc.23161. Epub 2019 Feb 25.

43.

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.

Faner R, Morrow JD, Casas-Recasens S, Cloonan SM, Noell G, López-Giraldo A, Tal-Singer R, Miller BE, Silverman EK, Agustí A, Hersh CP.

Respir Res. 2019 Jan 8;20(1):5. doi: 10.1186/s12931-018-0965-y.

44.

Development of a pharmaceutical care program in progressive stages in geriatric institutions.

Mestres C, Hernandez M, Agustí A, Puerta L, Llagostera B, Amorós P.

BMC Geriatr. 2018 Dec 19;18(1):316. doi: 10.1186/s12877-018-1002-1.

45.

Early Life Origins of Asthma: A Review of Potential Effectors.

Bobolea I, Arismendi E, Valero A, Agustí A.

J Investig Allergol Clin Immunol. 2019;29(3):168-179. doi: 10.18176/jiaci.0361. Epub 2018 Dec 18. Review.

46.

Are semantic and episodic autobiographical memories influenced by the life period remembered? Comparison of young and older adults.

Meléndez JC, Agusti AI, Satorres E, Pitarque A.

Eur J Ageing. 2018 Jan 19;15(4):417-424. doi: 10.1007/s10433-018-0457-4. eCollection 2018 Dec.

47.

Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease.

Demeyer H, Donaire-Gonzalez D, Gimeno-Santos E, Ramon MA, DE Battle J, Benet M, Serra I, Guerra S, Farrero E, Rodriguez E, Ferrer J, Sauleda J, Monso E, Gea J, Rodriguez-Roisin R, Agusti A, Antó JM, Garcia-Aymerich J.

Med Sci Sports Exerc. 2019 May;51(5):833-840. doi: 10.1249/MSS.0000000000001859.

PMID:
30531289
48.

Heterogeneity and complexity in bronchiectasis: A pending challenge.

Martinez-Garcia MA, Agustí A.

Arch Bronconeumol. 2019 Apr;55(4):187-188. doi: 10.1016/j.arbres.2018.09.010. Epub 2018 Nov 22. English, Spanish. No abstract available.

PMID:
30470557
49.

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Borràs-Santos A, Garcia-Aymerich J, Soler-Cataluña JJ, Vigil Giménez L, Gea Guiral J, Rodríguez Chiaradía D, Pascual-Guardia S, Marcos Rodríguez PJ, Alvarez Martinez CJ, Casanova Macario C, López-Campos JL, Carrasco Hernández L, Martínez-González C, Santos-Pérez S, Peces-Barba G, Molina Paris J, Román Rodríguez M, Barberà JA, Faner R, Agustí A, Cosío BG; en representación del Grupo Investigador del estudio EARLY COPD.

Arch Bronconeumol. 2019 Jun;55(6):312-318. doi: 10.1016/j.arbres.2018.09.007. Epub 2018 Nov 11. English, Spanish.

PMID:
30429076
50.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736

Supplemental Content

Loading ...
Support Center